*Department of Pediatrics, University of Miami Leonard M. Miller School of Medicine
†The Holtz Children's Hospital of the University of Miami/Jackson Memorial Medical Center
‡Sylvester Comprehensive Cancer Center, Miami, FL
§Dartmouth Medical School, Hanover, NH
∥Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Supported in part by a Bankhead Coley New Investigator Research Award, the National Institutes of Health (HL072705, HL078522, HL053392, CA127642, CA068484, HD052104, AI50274, CA068484, HD052102, HL087708, HL079233, HL004537, HL087000, HL007188, HL094100, HL095127, and HD80002), the Children’s Cardiomyopathy Foundation, the University of Miami Women’s Cancer Association, and the Lance Armstrong Foundation, the Michael Garil Fund, and the American Society of Hematology Trainee Research Award.
The authors declare no conflict of interest.
Reprints: Steven E. Lipshultz, MD, Department of Pediatrics (D820), University of Miami Leonard M. Miller School of Medicine, P.O. Box 016820, Miami, FL 33101 (e-mail: [email protected]).
Received August 26, 2011
Accepted February 28, 2012
